Cognition, memory, and focus is the main area connected here, and any felt benefit should be read together with the human evidence base.
Representative tier calculated from paper evidence that passed the collection audit.
The representative ingredient tier is calculated from these target-level evidence groups.
10 new papers were added in this period. No new risk signal was identified.
Standalone side-effect signals and combination cautions are listed separately.
The group showed a positive signal, but individual contributions are hard to isolate. Not a stack recommendation.
Paper IDs and full lists are private. Only study types and summaries are shown.
The herein reported results reinforce the potential of this novel immunotherapy to re-establish immunological tolerance, opening the door to new therapeutic approaches in the field of autoimmunity.
The current understanding of ApoEVs, in particular, the ApoEV subtype called apoptotic bodies (ApoBDs), is examined and a subset of ApoBDs can be larger than 5 μm and smaller than 1 μm based on flow cytometry and live time-lapse microscopy analysis, respective
Findings are indicated that DHA supplementation promotes phosphatidylserine accumulation and inhibits neuronal cell death under challenged conditions, supporting a notion that DHA is an important neuroprotective agent.
Short-term supplementation with PS+PA in patients with AD showed a stabilizing effect on daily functioning, emotional state and self-reported general condition, and the data encourage long-term studies with PS +PA in AD patients and other elderly with memory o
Phosphatidylserine and PS liposome could be a promising supplementation for neurodegenerative and neurodevelopmental diseases.
It is demonstrated that soybean-derived phosphatidylserine (SB-PS) may have favorable effects on cognitive function in elderly with memory complaints and suggests that SB-PS is safe for human consumption and may serve as a safe alternative to phosphate extract